AAA

ADAPTOGENICS HEALTH CORP.

No trades
See on Supercharts
Market capitalization
‪376.08 K‬CAD
−0.010CAD
‪−146.95 K‬CAD
‪1.12 K‬CAD
‪12.03 M‬
Beta (1Y)
−0.95

About ADAPTOGENICS HEALTH CORP.


CEO
Daryl Ware-Lane
Headquarters
Vancouver
Founded
2021
FIGI
BBG01C8VQW60
Adaptogenics Health Corp. engages in the formulation and distribution of functional mushroom products and nutritional supplement alternatives. Its products include mushroom tincture collection, chaga tincture, cordyceps tincture, lion's mane tincture, and functional mushroom bundle. The company was founded on April 1, 2021 and is headquartered in Vancouver, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ADPT is 0.030 CAD — it hasn't changed in the past 24 hours. Watch ADAPTOGENICS HEALTH CORP. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on CSE exchange ADAPTOGENICS HEALTH CORP. stocks are traded under the ticker ADPT.
ADPT stock has fallen by −16.67% compared to the previous week, the last month showed zero change in price, over the last year there was no change in ADAPTOGENICS HEALTH CORP. price.
ADPT reached its all-time high on Jan 12, 2023 with the price of 0.400 CAD, and its all-time low was 0.015 CAD and was reached on Nov 1, 2023. View more price dynamics on ADPT chart.
See other stocks reaching their highest and lowest prices.
ADPT stock is 16.67% volatile and has beta coefficient of −0.95. Track ADAPTOGENICS HEALTH CORP. stock price on the chart and check out the list of the most volatile stocks — is ADAPTOGENICS HEALTH CORP. there?
Yes, you can track ADAPTOGENICS HEALTH CORP. financials in yearly and quarterly reports right on TradingView.
ADPT net income for the last quarter is ‪−9.79 K‬ CAD, while the quarter before that showed ‪−50.88 K‬ CAD of net income which accounts for 80.76% change. Track more ADAPTOGENICS HEALTH CORP. financial stats to get the full picture.
No, ADPT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ADAPTOGENICS HEALTH CORP. EBITDA is ‪−137.51 K‬ CAD, and current EBITDA margin is ‪−13.62 K‬%. See more stats in ADAPTOGENICS HEALTH CORP. financial statements.
Like other stocks, ADPT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ADAPTOGENICS HEALTH CORP. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ADAPTOGENICS HEALTH CORP. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ADAPTOGENICS HEALTH CORP. stock shows the neutral signal. See more of ADAPTOGENICS HEALTH CORP. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.